Compliance
Item
likely to comply with study protocol
boolean
C1321605 (UMLS CUI [1])
Age
Item
age of 18-70
boolean
C0001779 (UMLS CUI [1])
multiple myeloma or lymphoma
Item
histologically proven multiple myeloma or lymphoma
boolean
C0026764 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
Cytotoxic agents
Item
not currently receiving cytotoxic agents however thalidomide, prednisolone, dexamethasone are allowable
boolean
C0304497 (UMLS CUI [1])
Bisphosphonates
Item
multiple myeloma patients must be receiving regular bisphosphonates
boolean
C0012544 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count between 1.5 and 10.0 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
ECOG
Item
ecog performance status </= 3
boolean
C1520224 (UMLS CUI [1])
Life expectancy
Item
life expectancy of at least two months
boolean
C0023671 (UMLS CUI [1])
Informed consent
Item
written informed consent signed by patient or legally authorised representative
boolean
C0021430 (UMLS CUI [1])
Vitamin A preparations
Item
use of other vitamin a preparations within the last 30 days
boolean
C0042839 (UMLS CUI [1])
Infection or fever
Item
active infection or fever >/= 38.2 degrees celsius
boolean
C0009450 (UMLS CUI [1])
C0015967 (UMLS CUI [2])
Pregnancy or Breast Feeding, Contraception
Item
pregnancy or breast feeding. women of child bearing potential admitted to the trial must take adequate measures to prevent conception (at least two different forms of contraception) and are to undergo a pregnancy test. oral contraception must not include low-dose progestogens
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Allergy to E. Coli derived products
Item
known allergy to e.coli derived products
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0014834 (UMLS CUI [1,3])
Tetracycline antibiotics
Item
current treatment with tetracycline antibiotics
boolean
C1744619 (UMLS CUI [1])